For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

Bamberg 96049

0 studies enrolling now · 3 studies all time

What they study most

Colorectal Cancer, Locally Advanced Squamous Non-Small Cell Lung Cancer, Metastatic Squamous Non-Small Cell Lung Cancer, Multiple Myeloma

Studies at this site

• A Study of Tabalumab (LY2127399) in Participants With Previously Treated Multiple Myeloma (MM) — Completed
• A Study of Gemcitabine-Carboplatin Plus Necitumumab (LY3012211) in Chemotherapy-Naïve Participants With Locally Advanced or Metastatic Squamous Non-Small Cell Lung Cancer (NSCLC) — Withdrawn before enrolling
• A Study in Second Line Metastatic Colorectal Cancer — Completed